| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 417.63B | 420.65B | 382.28B | 388.61B | 361.73B | 301.96B |
| Gross Profit | 121.19B | 118.23B | 102.51B | 109.64B | 120.36B | 97.55B |
| EBITDA | 51.82B | 52.51B | 64.04B | 34.93B | 67.83B | 56.45B |
| Net Income | 25.52B | 26.20B | 31.10B | 10.57B | 33.41B | 27.72B |
Balance Sheet | ||||||
| Total Assets | 504.85B | 533.79B | 532.25B | 522.87B | 484.66B | 448.82B |
| Cash, Cash Equivalents and Short-Term Investments | 32.87B | 27.37B | 42.78B | 30.08B | 47.27B | 51.97B |
| Total Debt | 34.55B | 28.28B | 10.51B | 29.84B | 20.52B | 20.62B |
| Total Liabilities | 148.57B | 175.79B | 168.53B | 183.56B | 162.82B | 150.57B |
| Stockholders Equity | 355.66B | 357.34B | 362.47B | 336.40B | 318.75B | 295.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.32B | 13.74B | -9.89B | 9.86B | 32.69B |
| Operating Cash Flow | 0.00 | 20.78B | 47.41B | 14.36B | 33.14B | 56.08B |
| Investing Cash Flow | 0.00 | -22.03B | -5.43B | -28.90B | -26.44B | -30.24B |
| Financing Cash Flow | 0.00 | -17.12B | -30.09B | -2.82B | -11.88B | -8.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥334.00B | 5.46 | 9.34% | 4.27% | -0.48% | -35.29% | |
79 Outperform | ¥344.12B | 14.16 | 9.59% | 3.91% | 0.87% | 16.71% | |
76 Outperform | ¥433.14B | 17.67 | 6.52% | 1.82% | 3.25% | -11.31% | |
74 Outperform | ¥303.55B | 9.05 | 5.47% | 3.41% | 2.60% | 9.50% | |
68 Neutral | ¥2.08T | 17.01 | 11.98% | 1.54% | 1.84% | -6.57% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥762.41B | 12.79 | 2.01% | 3.82% | -4.63% | -65.11% |